Advertisement
YOU ARE HERE: LAT HomeCollections

Business Briefing / Drugs

Allergan sues rival Watson

July 15, 2009|Times Wire Reports

Allergan Inc. of Irvine sued Corona-based Watson Pharmaceuticals Inc., alleging infringement of a U.S. patent for Sanctura XR, a prescription medicine used to treat overactive bladder.

Allergan, and business partners Endo Pharmaceuticals Solutions Inc. and Supernus Pharmaceuticals Inc., contend in a federal court complaint that Watson plans to market a generic version of Sanctura before the patent expires in 2025.

Watson did not immediately comment.

Advertisement
Los Angeles Times Articles
|
|
|